Related Experiment Video
Updated: Mar 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study
Francesco Violi1, Giovanni Davì, Marco Proietti
1Prof. Francesco Violi, I Clinica Medica, Sapienza-University of Rome, Viale del Policlinico 155, Rome, 00161, Italy, Tel.: +39 06 4461933, Fax: +39 06 49970103,
Insights
Low Ankle-Brachial Index (ABI) predicts vascular death and myocardial infarction (MI) in non-valvular atrial fibrillation (NVAF) patients. This finding aids cardiovascular risk assessment in this high-risk population.
Area of Science:
- Cardiology
- Vascular Medicine
- Atherosclerosis Research
Background:
- Atrial fibrillation (AF) patients face elevated risks of thrombotic and vascular events due to cardiac arrhythmia and systemic atherosclerosis.
- The Ankle-Brachial Index (ABI) is a validated, non-invasive measure of systemic atherosclerosis and cardiovascular event prediction in the general population.
- Limited data exist on the utility of ABI in predicting vascular events specifically within the non-valvular atrial fibrillation (NVAF) patient cohort.
Purpose of the Study:
- To investigate the association between a low Ankle-Brachial Index (ABI ≤ 0.90) and the occurrence of vascular events in patients with non-valvular atrial fibrillation (NVAF).
- To determine if low ABI is an independent predictor of vascular events, vascular death, and myocardial infarction (MI) in NVAF patients.
Main Methods:
- The ARAPACIS study enrolled 2,027 out- or in-patients with NVAF across 136 Italian centers.
- Patients were followed for a median of 34.7 months, with data collected on vascular events, vascular death, and myocardial infarction (MI).
- Cox proportional hazard analysis was employed to assess the predictive value of ABI ≤ 0.90 for vascular events.
Main Results:
- A total of 176 patients (8.7%) experienced a vascular event over 4,614 patient-years of observation.
- Low ABI (≤ 0.90) was significantly more prevalent in patients who experienced vascular events (32.2% vs. 20.2%, p<0.05).
- ABI ≤ 0.90 independently predicted vascular events (HR: 1.394), vascular death (HR: 2.047), and MI (HR: 2.709) in NVAF patients.
Conclusions:
- A low Ankle-Brachial Index (ABI) is a valuable, independent predictor of myocardial infarction (MI) and vascular death in non-valvular atrial fibrillation (NVAF) patients.
- Incorporating ABI measurement into routine assessments can enhance cardiovascular risk stratification for NVAF patients.
- Low ABI did not show an association with stroke or transient ischemic attack in this NVAF cohort.
Abstract:
Atrial fibrillation (AF) patients are at high risk for thrombotic and vascular events related to their cardiac arrhythmia and underlying systemic atherosclerosis. Ankle-Brachial Index (ABI) is a non-invasive tool in evaluating systemic atherosclerosis, useful in predicting cardiovascular events in general population; no data are available in AF patients. ARAPACIS is a prospective multicentre observational study performed by the Italian Society of Internal Medicine, analysing association between low ABI (≤ 0.90) and vascular events in NVAF out- or in-patients, enrolled in 136 Italian centres. A total of 2,027 non-valvular AF (NVAF) patients aged > 18 years from both sexes followed for a median time of 34.7 (interquartile range: 22.0-36.0) months, yielding a total of 4,614 patient-years of observation. Mean age was 73 ± 10 years old with 55 % male patients. A total of 176 patients (8.7 %) experienced a vascular event, with a cumulative incidence of 3.81 %/patient-year. ABI≤ 0.90 was more prevalent in patients with a vascular event compared with patients free of vascular events (32.2 vs 20.2 %, p< 0.05). On Cox proportional hazard analysis, ABI≤ 0.90 was an independent predictor of vascular events (hazard ratio (HR): 1.394, 95 % confidence interval (CI): 1.042-1.866; p=0.02), vascular death (HR: 2.047, 95 % CI: 1.255-3.338; p=0.004) and MI (HR: 2.709, 95 % CI: 1.485-5.083; p=0.001). This latter association was also confirmed after excluding patients with previous MI (HR: 2.901, 95 % CI: 1.408-5.990, p=0.004). No association was observed between low ABI and stroke/transient ischaemic attack (p=0.91). In conclusion, low ABI is useful to predict MI and vascular death in NVAF patients and may independently facilitate cardiovascular risk assessment in NVAF patients.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of blood pressure in brachial artery(two-step method)
Pre-Procedural Guidelines for Assessing Blood Pressure
Sites for measuring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement

